contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      viewerIsFollowing
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
      tags {
        viewerIsFollowing
        id
      }
    }
    ... on Webcast {
      liveTime
      tags {
        viewerIsFollowing
        id
      }
    }
    slug
    ... on CompanyReport {
      tags {
        viewerIsFollowing
        id
      }
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


ghp-divests-urologcentrum-odenplan-positive-impact-on-result-in-fourth-quarter-2020

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

GHP Specialty Care AB (‘GHP‘) has today, through subsidiary, entered into an agreement to divest its holding in the partly owned company GHP Urologcentrum Odenplan AB (‘Urologcentrum Odenplan...

<div class="mfn-body"><p>GHP Specialty Care AB (‘<strong>GHP</strong>‘) has today, through subsidiary, entered into an agreement to divest its holding in the partly owned company GHP Urologcentrum Odenplan AB (‘<strong>Urologcentrum Odenplan</strong>’). The divestment will have a positive impact on the result in the fourth quarter 2020 of about SEK 19 million (on-time item).</p><p>The consideration amounts to SEK 24,283,000 with additional interest of 4% until access date. The divestment is not conditioned to approval and will be completed in October 2020. Urologcentrum Odenplan performs diagnostics and treatment services within urology. The divested operation’s net revenue amounted to SEK 26,395,000 in 2019. The buyer is Colosseum Man Holding AS. The divestment is a natural part of GHP’s business, and GHP will continue to provide urology services in its operations.</p><p><em>“GHP continues to invest in the field of urology, partly through our other existing urology clinics in Stockholm and Skåne. Going forward our strategy is to grow, both organically and through acquisitions. In this unique case, however, we have in dialouge with our partners agreed that a sale is a good opportunity.”</em> says Daniel Öhman, CEO GHP.</p></div><div class="mfn-footer mfn-contacts"><p><strong class="mfn-heading-1">Contacts</strong></p><hr/><p><strong>Daniel Öhman, CEO</strong><br/>Tel: +46 (0) 708 55 37 07</p><p><strong>Philip Delborn, CFO</strong><br/>Tel: +46 (0) 702 12 52 64</p></div><div class="mfn-footer mfn-about"><p><strong>About Us</strong></p><hr/><p><em>GHP is an internationally active health care provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the health care industry, where leading doctors and medical staff become partners and shareholders. Each clinic specialises in a particular patient group, and this leads to increased efficiency and higher quality. This is the cornerstone of GHP’s business philosophy – “Quality through specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm under the ticker symbol “GHP”.</em></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that GHP Specialty Care is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2020-09-30 18:30 CEST.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-pdf"><p><strong class="mfn-heading-1">Attachments</strong></p><hr/><p><a class="mfn-generated mfn-primary" href="https://storage.mfn.se/ff6562b0-3b8b-4705-b31e-7ba765b968e5/ghp-divests-urologcentrum-odenplan-positive-impact-on-result-in-fourth-quarter-2020.pdf" target="_blank" rel="nofollow noopener">GHP divests Urologcentrum Odenplan - positive impact on result in fourth quarter 2020</a></p></div>

GHP divests Urologcentrum Odenplan - positive impact on result in fourth quarter 2020